What is the current Theraclion market capitalization?
The current market capitalization of Theraclion is 10.34 M EUR.
Theraclion Market capitalization 2024
Theraclion Market capitalization
10.34 M EUR
Ticker
ALTHE.PA
ISIN
FR0010120402
WKN
A112C8
In 2024, Theraclion's market cap stood at 10.34 M EUR, a -41.68% increase from the 17.74 M EUR market cap in the previous year.
The Theraclion Market capitalization history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) | NET INCOME (undefined EUR) |
|---|---|---|---|
| 2025e | 43.56 | 1,77 | - |
| 2024e | 12.36 | 6,22 | 4.71 |
| 2023e | 8.24 | 9,34 | - |
| 2022 | 1.24 | 62,27 | -4.96 |
| 2021 | 1.48 | 69,02 | -3.76 |
| 2020 | 0.74 | 60,91 | -3.91 |
| 2019 | 2.78 | 42,07 | -3.79 |
| 2018 | 1.93 | 44,02 | -6.14 |
| 2017 | 2.43 | 40,88 | -6.22 |
| 2016 | 1.89 | 46,76 | -6.81 |
| 2015 | 1.53 | -214,55 | -6.41 |
| 2014 | 0.8 | -248,47 | -4.63 |
| 2013 | 0.01 | -21800,00 | -4.11 |
| 2012 | - | - | -3.07 |
| 2011 | - | - | -1.68 |
| 2010 | - | - | -1.92 |
Theraclion Aktienanalyse
What does Theraclion do?
Theraclion SA is a French medical company specializing in the development and production of innovative therapy systems. The company was founded in 2004 and is headquartered in Malakoff, France. Theraclion's business model is based on the development and marketing of medical devices based on High Intensity Focused Ultrasound (HIFU) technology. This technology uses ultrasound pulses to treat targeted areas in the body without the need for surgical intervention. Theraclion specializes in three main areas: oncology, dermatology, and aesthetics. In the field of oncology, Theraclion has developed the Echopulse system, which is used for the treatment of breast tumors. The system applies high-intensity ultrasound pulses to kill tumor cells without damaging surrounding tissue. This non-invasive method of tumor treatment is very promising and has already shown promising results in several studies. In the field of dermatology, Theraclion has developed the Echovist system, which is used for the treatment of nevi (moles). The system also utilizes HIFU technology to destroy the nevi, resulting in a significant improvement in the aesthetic appearance of the skin. In the field of aesthetics, Theraclion has developed the Sonovein system, which is used for the treatment of varicose veins. The system also utilizes HIFU technology to close the veins and thus improve the patient's appearance and quality of life. Theraclion has experienced impressive growth in recent years and is now an important player in the medical industry. The company has filed several patents and works closely with leading doctors and research institutions to maximize the effectiveness of its products. Overall, Theraclion aims to offer innovative therapies that meet the needs of patients and help them lead fulfilling lives. The company is committed to continuously improving its products and services and strives to achieve even greater successes in the future. Theraclion ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Theraclion's Market Capitalization
Theraclion's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Theraclion's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Theraclion's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Theraclion’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Theraclion Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Theraclion.
How has the market capitalization of Theraclion developed in recent years?
The market capitalization of Theraclion has increased/decreased by -41.68% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Theraclion?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Theraclion?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Theraclion have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Theraclion pay?
Over the past 12 months, Theraclion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Theraclion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Theraclion?
The current dividend yield of Theraclion is .
When does Theraclion pay dividends?
Theraclion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Theraclion?
Theraclion paid dividends every year for the past 0 years.
What is the dividend of Theraclion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Theraclion located?
Theraclion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Theraclion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Theraclion from 6/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/29/2024.
When did Theraclion pay the last dividend?
The last dividend was paid out on 6/29/2024.
What was the dividend of Theraclion in the year 2023?
In the year 2023, Theraclion distributed 0 EUR as dividends.
In which currency does Theraclion pay out the dividend?
The dividends of Theraclion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Theraclion
Our stock analysis for Theraclion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Theraclion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
